Epithelial ovarian cancer risk: a review of the current genetic landscape. Flaum Nicola et al. Clinical genetics 2019 May

Main|Search|PHGKB




Last Posted: May 20, 2019

---

• Epithelial ovarian cancer risk: a review of the current genetic landscape.
  Flaum Nicola et al. Clinical genetics 2019 May
• Accuracy in risk understanding among BRCA1/2-mutation carriers.
  Speiser Dorothee et al. Patient education and counseling 2019 May
• Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer.
  Nicolussi Arianna et al. PeerJ 2019 7e6661
• Novel Nanochip Paves Way for Early Ovarian Cancer Detection.
  Abbasi Jennifer et al. JAMA 2019 May 321(18) 1759
• The influence of BRCA variants of unknown significance on cancer risk management decision-making.
  Chern Jing Yi et al. Journal of gynecologic oncology 2019 Feb
• Universal tumor DNA BRCA1/2 testing of ovarian cancer: prescreening PARPi treatment and genetic predisposition.
  Vos Janet R et al. Journal of the National Cancer Institute 2019 May
• Direct Genetics Referral Pathway for High-Grade Serous Ovarian Cancer Patients: The "Opt-Out" Process.
  McGee Jacob et al. Journal of oncology 2019 20196029097
• Prediction of survival outcomes in patients with epithelial ovarian cancer using machine learning methods.
  Paik E Sun et al. Journal of gynecologic oncology 2019 Mar
• Prevalence and characteristics of likely-somatic variants in cancer susceptibility genes among individuals who had hereditary pan-cancer panel testing.
  Slavin Thomas P et al. Cancer genetics 2019 Apr
• Trends in BRCA testing and socioeconomic deprivation.
  Martin Antony P et al. European journal of human genetics : EJHG 2019 May

more